NeuroBo Pharmaceuticals (NRBO) Stock Chart & Stock Price History $2.67 +0.10 (+3.89%) (As of 11/1/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends NeuroBo Pharmaceuticals Stock Price Performance5 Day Performance-6.32%1 Month Performance-0.74%3 Month Performance-32.91%6 Month Performance-28.42%Year-To-Date Performance-27.77%1 Year Performance-19.35% Receive NRBO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NeuroBo Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Paradigm PressEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.Click here to see it because it’s a SHOCKER… NRBO Stock Chart for Saturday, November, 2, 2024 NRBO Chart by TradingView NeuroBo Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/01/2024$2.57$2.67+3.89%$2.91$2.5463,094 shs$21.95 million10/31/2024$2.65$2.57-3.02%$2.75$2.5311,834 shs$21.13 million10/30/2024$2.86$2.65-7.34%$2.98$2.6319,047 shs$21.79 million10/29/2024$2.85$2.86+0.35%$2.92$2.5536,679 shs$23.51 million10/28/2024$2.78$2.85+2.52%$3.00$2.7332,284 shs$23.43 million10/25/2024$2.80$2.78-0.71%$3.12$2.7530,290 shs$13.64 million Get the Latest News and Ratings for NRBO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NeuroBo Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 10/24/2024$2.83$2.80-1.06%$2.97$2.7211,608 shs$13.74 million10/23/2024$2.88$2.83-1.74%$2.93$2.7513,897 shs$13.88 million10/22/2024$2.92$2.88-1.37%$3.00$2.7510,223 shs$14.13 million10/21/2024$3.03$2.92-3.63%$3.15$2.9215,669 shs$14.33 million10/18/2024$3.16$3.03-4.11%$3.16$2.9619,547 shs$14.87 million10/17/2024$2.96$3.16+6.76%$3.27$2.88112,046 shs$15.50 million10/16/2024$2.53$2.96+17.00%$2.98$2.6095,194 shs$14.52 million10/15/2024$2.54$2.53-0.39%$2.69$2.4815,042 shs$12.41 million10/14/2024$2.56$2.54-0.78%$2.63$2.4430,681 shs$12.46 million10/11/2024$2.47$2.56+3.64%$2.58$2.4127,538 shs$21.04 million10/10/2024$2.67$2.47-7.49%$2.67$2.0879,532 shs$12.12 million10/09/2024$2.65$2.67+0.75%$2.77$2.6026,363 shs$13.10 million10/08/2024$2.70$2.65-1.85%$2.80$2.6419,697 shs$13.00 million10/07/2024$2.73$2.70-1.10%$2.77$2.6524,964 shs$13.25 million10/04/2024$2.65$2.73+3.02%$2.93$2.6529,669 shs$13.39 million10/03/2024$2.69$2.65-1.49%$2.71$2.6027,414 shs$13.00 million10/02/2024$2.93$2.69-8.19%$3.00$2.56138,522 shs$13.20 million10/01/2024$3.17$2.93-7.57%$3.18$2.87100,649 shs$14.38 million09/30/2024$3.32$3.17-4.52%$3.50$3.06269,541 shs$15.55 million09/27/2024$3.29$3.32+0.91%$3.35$3.1744,525 shs$16.29 million09/26/2024$3.32$3.29-0.90%$3.46$3.1645,760 shs$27.04 million09/25/2024$3.20$3.32+3.75%$3.36$3.1641,794 shs$27.29 million09/24/2024$3.19$3.20+0.31%$3.36$3.1934,660 shs$15.70 million09/23/2024$3.19$3.19$3.45$3.1956,818 shs$15.65 million09/20/2024$3.26$3.19-2.15%$3.35$3.0875,308 shs$15.65 million09/19/2024$3.40$3.26-4.12%$3.57$3.2661,733 shs$15.99 million09/18/2024$3.43$3.40-0.87%$3.72$3.3533,250 shs$16.68 million09/17/2024$3.44$3.43-0.29%$3.71$3.3331,500 shs$16.83 million09/16/2024$3.61$3.44-4.71%$3.75$3.4469,775 shs$16.88 million09/13/2024$3.65$3.61-1.10%$3.82$3.5056,609 shs$17.71 million09/12/2024$3.75$3.65-2.67%$3.93$3.6031,039 shs$17.91 million09/11/2024$3.88$3.75-3.35%$4.20$3.6745,273 shs$18.40 million09/10/2024$4.11$3.88-5.60%$4.31$3.8870,717 shs$19.04 million09/09/2024$3.50$4.11+17.43%$4.32$3.65109,168 shs$20.16 millionCrypto Crash Ahead? (27 Experts Weigh In) (Ad)Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!Click here to reserve your spot at the emergency crypto summit now.09/06/2024$3.36$3.50+4.17%$3.74$3.2860,720 shs$17.17 million09/05/2024$3.37$3.36-0.30%$3.52$3.3014,721 shs$16.48 million09/04/2024$3.51$3.37-3.96%$3.57$3.2218,899 shs$27.70 million09/03/2024$3.69$3.51-4.91%$3.74$3.5022,860 shs$28.84 million09/02/2024$3.69$3.69$3.70$3.572,700 shs$30.33 million08/30/2024$3.51$3.68+4.84%$3.70$3.572,459 shs$18.05 million08/29/2024$3.48$3.51+0.86%$3.63$3.497,413 shs$17.22 million08/28/2024$3.46$3.48+0.58%$3.62$3.467,290 shs$17.07 million08/27/2024$3.47$3.46-0.29%$3.77$3.4151,393 shs$16.98 million08/26/2024$3.40$3.47+2.06%$3.72$3.3317,667 shs$17.02 million08/23/2024$3.65$3.40-6.85%$3.78$3.3068,748 shs$16.68 million08/22/2024$3.77$3.65-3.18%$3.94$3.5714,406 shs$17.91 million08/21/2024$3.77$3.77$3.84$3.659,104 shs$18.50 million08/20/2024$3.90$3.77-3.33%$3.95$3.6413,979 shs$18.50 million08/19/2024$3.66$3.90+6.56%$3.91$3.7214,651 shs$19.13 million08/16/2024$3.91$3.66-6.39%$3.98$3.6321,203 shs$17.96 million08/15/2024$4.01$3.91-2.49%$4.11$3.7715,239 shs$19.18 million08/14/2024$3.72$4.01+7.80%$4.19$3.6770,168 shs$19.67 million08/13/2024$3.69$3.72+0.81%$3.88$3.5714,202 shs$18.25 million08/12/2024$3.60$3.69+2.50%$3.96$3.5013,379 shs$18.10 million08/09/2024$3.80$3.60-5.26%$4.02$3.6050,804 shs$17.66 million08/08/2024$3.85$3.80-1.30%$3.93$3.5627,864 shs$18.64 million08/07/2024$3.87$3.85-0.52%$3.93$3.798,974 shs$21.83 million08/06/2024$3.57$3.87+8.40%$3.92$3.5451,623 shs$21.94 million08/05/2024$3.99$3.57-10.41%$3.86$3.5041,055 shs$20.24 million08/02/2024$3.78$3.98+5.29%$4.03$3.6931,401 shs$22.57 million08/01/2024$4.07$3.78-7.13%$4.17$3.7541,977 shs$21.43 million Related Companies Galmed Pharmaceuticals Stock Price Chart Oramed Pharmaceuticals Stock Price Chart InflaRx Stock Price Chart Oncolytics Biotech Stock Price Chart Aileron Therapeutics Stock Price Chart Kazia Therapeutics Stock Price Chart Purple Biotech Stock Price Chart BeyondSpring Stock Price Chart Virios Therapeutics Stock Price Chart MediciNova Stock Price Chart Receive NRBO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for NeuroBo Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:NRBO) was last updated on 11/2/2024 by MarketBeat.com Staff From Our PartnersEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeuroBo Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NeuroBo Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
